A Phase I PK Study of Balcinrenone/Dapagliflozin in Healthy Chinese Participants

Clinical trial NCT06651021 · COMPLETED

Trial details

NCT number: NCT06651021
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer

Start date: 2024-10-21
Primary completion: 2024-10-28
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.